19 Jun, 2013
The Leela Palace, Bengaluru
Home >> M & A >>
Wednesday, July 11, 2012 - 12:47 IST
Adcock Ingram buys Cosme Farma’s drug portfolio for $86M
BY Madhav A Chanchani
The all-cash transaction has been done at a premium of nearly 13 times Cosme Farma’s EBITDA.
South Africa’s Adcock Ingram has acquired the pharmaceutical brands of privately held Cosme Farma Laboratories Ltd for Rs 480 crore ($86 million). The all-cash deal will see the acquisition of Cosme Pharma’s portfolio in areas like dermatology and...
To continue reading this article, you must be a Premium subscriber...
A Premium membership gives you:
- Access to all premium articles including exclusives, analyses & commentary.
- Access to archives of over six years.
- Exclusive interviews with top fund managers, CEOs and bankers.
JOBS
- Associate - Red Fort Capital Advisors Pvt Ltd
- The Private Equity Associate - Nereus Capital
RECENT COMMENTS
- 23 May 2013Murali ApparajuonInteresting surmises! What makes the takeaways less validated however is the lack of disclosure or at least a...
- 23 May 2013VaradhaonPhoenix LP's are managing your money and my money - so they ought to maintain an arm's length and review...
- 21 May 2013PhoenixonWell said Varadha. This comment of your is unclear, " LPs ought to maintain an arm's distance from GPs and...
- 21 May 2013AnooponThe biggest problem in Indian PE fund GPs is Ethics. They want Day-One-Carry rather than long term carry. There should...
UPCOMING EVENTSchinetwork